We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECK icon
601
Teck Resources
TECK
$28.2B
$498K ﹤0.01%
9,532
+635
+7% +$30.2K
RCI icon
602
Rogers Communications
RCI
$18.8B
$468K ﹤0.01%
11,620
-2,185
-16% -$85.5K
GAP
603
The Gap Inc
GAP
$7.3B
$456K ﹤0.01%
20,659
+3,612
+21% +$80.2K
CVX icon
604
Chevron
CVX
$382B
$447K ﹤0.01%
3,032
– –
NTR icon
605
Nutrien
NTR
$33.9B
$443K ﹤0.01%
9,217
+1,611
+21% +$77.7K
SU icon
606
Suncor Energy
SU
$77.7B
$431K ﹤0.01%
11,658
+2,462
+27% +$95.1K
OSK icon
607
Oshkosh
OSK
$8.91B
$418K ﹤0.01%
4,175
+717
+21% +$74.7K
IPG
608
DELISTED
Interpublic Group of Companies
IPG
$388K ﹤0.01%
12,257
– –
TU icon
609
Telus
TU
$17.4B
$377K ﹤0.01%
22,448
– –
POOL icon
610
Pool Corp
POOL
$7.05B
$376K ﹤0.01%
997
– –
CCJ icon
611
Cameco
CCJ
$36.8B
$375K ﹤0.01%
7,833
-383
-5% -$16.7K
TRP icon
612
TC Energy
TRP
$70.1B
$371K ﹤0.01%
7,793
-1,304
-14% -$56.7K
CNQ icon
613
Canadian Natural Resources
CNQ
$96.9B
$364K ﹤0.01%
10,941
+3,055
+39% +$106K
IP icon
614
International Paper
IP
$22.6B
$344K ﹤0.01%
7,039
+618
+10% +$28.8K
WFC icon
615
Wells Fargo
WFC
$254B
$341K ﹤0.01%
6,032
– –
ITUB icon
616
Itaú Unibanco
ITUB
$89.8B
$336K ﹤0.01%
57,298
– –
UBER icon
617
Uber
UBER
$145B
$334K ﹤0.01%
4,449
– –
BBD icon
618
Banco Bradesco
BBD
$37.4B
$313K ﹤0.01%
117,801
+66,266
+129% +$170K
PHM icon
619
Pultegroup
PHM
$25.2B
$305K ﹤0.01%
+2,124
New +$270K
TRI icon
620
Thomson Reuters
TRI
$46.4B
$303K ﹤0.01%
1,745
-365
-17% -$61.6K
ANF icon
621
Abercrombie & Fitch
ANF
$4.55B
$294K ﹤0.01%
+2,102
New +$320K
GPC icon
622
Genuine Parts
GPC
$17.9B
$283K ﹤0.01%
2,023
– –
KGC icon
623
Kinross Gold
KGC
$27.7B
$268K ﹤0.01%
28,538
+1,152
+4% +$10.3K
TPL icon
624
Texas Pacific Land
TPL
$26.9B
$265K ﹤0.01%
900
– –
YUMC icon
625
Yum China
YUMC
$15.7B
$263K ﹤0.01%
+5,842
New +$194K
23 24
25
26 27

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.